BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28888072)

  • 1. Characterization of isolated amyloid myopathy.
    Liewluck T; Milone M
    Eur J Neurol; 2017 Dec; 24(12):1437-1445. PubMed ID: 28888072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic Immunoglobulin Light Chain Amyloidosis-Associated Myopathy: Presentation, Diagnostic Pitfalls, and Outcome.
    Muchtar E; Derudas D; Mauermann M; Liewluck T; Dispenzieri A; Kumar SK; Dingli D; Lacy MQ; Buadi FK; Hayman SR; Kapoor P; Leung N; Chakraborty R; Gonsalves W; Russell S; Lust JA; Lin Y; Go RS; Zeldenrust S; Kyle RA; Rajkumar SV; Gertz MA
    Mayo Clin Proc; 2016 Oct; 91(10):1354-1361. PubMed ID: 27712634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intramuscular interstitial amyloid deposition does not impact anoctaminopathy-5 phenotype.
    Anandan C; Milone M; Liewluck T
    Muscle Nerve; 2019 Jan; 59(1):133-137. PubMed ID: 30320887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular amyloidosis: Unmasking the master of disguise.
    Pinto MV; Dyck PJB; Liewluck T
    Muscle Nerve; 2021 Jul; 64(1):23-36. PubMed ID: 33458861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transthyretin amyloidosis: Putting myopathy on the map.
    Pinto MV; Milone M; Mauermann ML; Dyck PJB; Alhammad R; McPhail ED; Grogan M; Liewluck T
    Muscle Nerve; 2020 Jan; 61(1):95-100. PubMed ID: 31587306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid myopathy: clinicopathologic study of 16 cases.
    Prayson RA
    Hum Pathol; 1998 May; 29(5):463-8. PubMed ID: 9596269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of amyloid myopathy diagnosed during the treatment of myopathy associated with anti-signal recognition particle antibodies].
    Kawakami N; Katsuyama Y; Hagiwara Y; Yoshida H; Kim K; Harada K
    Rinsho Shinkeigaku; 2017 Apr; 57(4):168-173. PubMed ID: 28367947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated myopathy as the initial manifestation of primary systemic amyloidosis.
    Karacostas D; Soumpourou M; Mavromatis I; Karkavelas G; Poulios I; Milonas I
    J Neurol; 2005 Jul; 252(7):853-4. PubMed ID: 15742103
    [No Abstract]   [Full Text] [Related]  

  • 9. Amyloid myopathy presenting with distal atrophic weakness.
    Smestad C; Monstad P; Lindboe CF; Mygland A
    Muscle Nerve; 2004 Apr; 29(4):605-9. PubMed ID: 15052628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic light chain amyloidosis myopathy responsive to daratumumab monotherapy.
    Chitimus DM; Berling E; Garderet L; Venturelli N; Malfatti E; Authier FJ; Nicolas G; LaforĂȘt P; Lefeuvre C
    Eur J Neurol; 2023 Mar; 30(3):745-748. PubMed ID: 36403110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexisting sporadic late onset nemaline myopathy and AL amyloid myopathy - incidental or related?
    Moshe-Lilie O; Banks G; Medvedova E; Masri A; Chahin N
    Neuromuscul Disord; 2022 Jun; 32(6):533-538. PubMed ID: 35550111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid myopathy presenting with rhabdomyolysis: evidence of complement activation.
    Rodolico C; Mazzeo A; Toscano A; Pastura C; Maimone D; Musumeci O; Musolino C; Vita G
    Neuromuscul Disord; 2006 Aug; 16(8):514-7. PubMed ID: 16919949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic outcome of muscle biopsy.
    Shaibani A; Jabari D; Jabbour M; Arif C; Lee M; Rahbar MH
    Muscle Nerve; 2015 May; 51(5):662-8. PubMed ID: 25187298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teaching neuroimages: dyspnea as a presenting manifestation of amyloid myopathy.
    Ghosh PS; Thaera GM; Tracy JA
    Neurology; 2013 Dec; 81(24):e184. PubMed ID: 24323446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid myopathy: characteristic features of a still underdiagnosed disease.
    Chapin JE; Kornfeld M; Harris A
    Muscle Nerve; 2005 Feb; 31(2):266-72. PubMed ID: 15478123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Case of amyloidosis with amyloid deposition detected only in skeletal muscles].
    Ohtsuka Y; Yasui N; Sekiguchi K; Kowa H; Nishino I; Kanda F; Toda T
    Rinsho Shinkeigaku; 2012; 52(10):739-43. PubMed ID: 23064623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal gammopathy of renal significance (MGRS)-related AL amyloidosis complicated by amyloid myopathy: a case report.
    Ono E; Ishii A; Higashi Y; Koita N; Ayaki T; Tanigaki K; Takayanagi S; Kondo N; Sakai K; Endo S; Yokoi H; Matsubara T; Minamiguchi S; Nishino I; Takahashi R; Yanagita M
    BMC Nephrol; 2021 Feb; 22(1):74. PubMed ID: 33639890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI evaluation of amyloid myopathy.
    Metzler JP; Fleckenstein JL; White CL; Haller RG; Frenkel EP; Greenlee RG
    Skeletal Radiol; 1992; 21(7):463-5. PubMed ID: 1439899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myopathy associated with amyloid angiopathy.
    Bruni J; Bilbao JM; Pritzker PH
    Can J Neurol Sci; 1977 Feb; 4(1):77-80. PubMed ID: 837267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal gammopathy with both nemaline myopathy and amyloid myopathy.
    Wang M; Lei L; Chen H; Di L; Pang M; Lu Y; Lu L; Shen XM; Da Y
    Neuromuscul Disord; 2017 Oct; 27(10):942-946. PubMed ID: 28606401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.